Extra Strength Tylenol "doctors recommend" claim too "all-encompassing," NAD says.
This article was originally published in The Tan Sheet
Executive Summary
McNEIL EXTRA STRENGTH TYLENOL "DOCTORS RECOMMEND" AD CLAIM is too broad and should be modified in future advertising, the National Advertising Division of the Council of Better Business Bureaus recommended in a March 5 Case Report. The watchdog agency took issue with the "all-encompassing quality" of McNeil's claim that doctors recommend Extra Strength Tylenol more than aspirin and ibuprofen for types of pain "from post-surgical pain to headaches." The television ads, created by Saatchi & Saatchi, New York, were brought before NAD by Advil maker American Home Products.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: